icone plus
Contact Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
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
MkDHx4d0kfJ6pKx7
Listen
